Literature DB >> 17472722

Respiratory syncytial virus differentially activates murine myeloid and plasmacytoid dendritic cells.

Ivette Boogaard1, Marijke van Oosten, Leonie S van Rijt, Femke Muskens, Tjeerd G Kimman, Bart N Lambrecht, Anne-Marie Buisman.   

Abstract

Respiratory syncytial virus (RSV) is the primary cause of bronchiolitis in young children. Upon infection both T helper 1 (Th1) and Th2 cytokines are produced. Because RSV-induced Th2 responses have been associated with severe immunopathology and aggravation of allergic reactions, the regulation of the immune response following RSV infection is crucial. In this study we examined the influence of RSV on the activation and function of murine bone marrow-derived dendritic cells (DCs). RSV induced the expression of maturation markers on myeloid DCs (mDCs) in vitro. The mDCs stimulated with RSV and ovalbumin (OVA) enhanced proliferation of OVA-specific T cells, which produced both Th1 and Th2 cytokines. In contrast to mDCs, RSV did not induce the expression of maturation markers on plasmacytoid DCs (pDCs), not did it enhance the proliferation of OVA-specific T cells that were cocultured with pDCs. However, RSV stimulated the production of interferon-alpha (IFN-alpha) by pDCs. Our findings indicate a clear difference in the functional activation of DC subsets. RSV-stimulated mDCs may have immunostimulatory effects on both Th1 and Th2 responses, while RSV-stimulated pDCs have direct antiviral activity through the release of IFN-alpha.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17472722      PMCID: PMC2265980          DOI: 10.1111/j.1365-2567.2007.02613.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

Review 1.  T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal.

Authors:  P Kaliński; C M Hilkens; E A Wierenga; M L Kapsenberg
Journal:  Immunol Today       Date:  1999-12

2.  Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry.

Authors:  K Bendelja; A Gagro; A Bace; R Lokar-Kolbas; V Krsulovic-Hresic; V Drazenovic; G Mlinaric-Galinovic; S Rabatic
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels.

Authors:  Koichi Hashimoto; Joan E Durbin; Weisong Zhou; Robert D Collins; Samuel B Ho; Jay K Kolls; Patricia J Dubin; James R Sheller; Kasia Goleniewska; Jamye F O'Neal; Sandra J Olson; Daphne Mitchell; Barney S Graham; R Stokes Peebles
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

4.  Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

Authors:  N Sigurs; R Bjarnason; F Sigurbergsson; B Kjellman
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

Review 5.  Activation of plasmacytoid dendritic cells.

Authors:  Martina Fuchsberger; Hubertus Hochrein; Meredith O'Keeffe
Journal:  Immunol Cell Biol       Date:  2005-10       Impact factor: 5.126

6.  Role for innate IFNs in determining respiratory syncytial virus immunopathology.

Authors:  Teresa R Johnson; Sara E Mertz; Negin Gitiban; Sue Hammond; Robin Legallo; Russell K Durbin; Joan E Durbin
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

7.  Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation.

Authors:  B N Lambrecht; M De Veerman; A J Coyle; J C Gutierrez-Ramos; K Thielemans; R A Pauwels
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

8.  Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice.

Authors:  A Boelen; A Andeweg; J Kwakkel; W Lokhorst; T Bestebroer; J Dormans; T Kimman
Journal:  Vaccine       Date:  2000-11-22       Impact factor: 3.641

9.  Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity.

Authors:  A H Brandenburg; A Kleinjan; B van Het Land; H A Moll; H H Timmerman; R L de Swart; H J Neijens; W Fokkens; A D Osterhaus
Journal:  J Med Virol       Date:  2000-10       Impact factor: 2.327

10.  Regulation of Toll-like receptors in human monocytes and dendritic cells.

Authors:  A Visintin; A Mazzoni; J H Spitzer; D H Wyllie; S K Dower; D M Segal
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

View more
  12 in total

1.  Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection.

Authors:  Natalie J Thornburg; Bryan Shepherd; James E Crowe
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Autophagy-mediated dendritic cell activation is essential for innate cytokine production and APC function with respiratory syncytial virus responses.

Authors:  Susan Morris; Michele S Swanson; Andrew Lieberman; Michelle Reed; Zhenyu Yue; Dennis M Lindell; Nicholas W Lukacs
Journal:  J Immunol       Date:  2011-09-12       Impact factor: 5.422

3.  Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection.

Authors:  Stephania A Cormier; Bishwas Shrestha; Jordy Saravia; Greg I Lee; Li Shen; John P DeVincenzo; Young-In Kim; Dahui You
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

4.  NKG2D Regulation of Lung Pathology and Dendritic Cell Function Following Respiratory Syncytial Virus Infection.

Authors:  Huan Liu; Andrew R Osterburg; Jennifer Flury; Shuo Huang; Francis X McCormack; Stephania A Cormier; Michael T Borchers
Journal:  J Infect Dis       Date:  2018-10-20       Impact factor: 5.226

5.  Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells.

Authors:  Pablo A González; Carolina E Prado; Eduardo D Leiva; Leandro J Carreño; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

6.  CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC.

Authors:  Lara E Kallal; Matthew A Schaller; Dennis M Lindell; Sergio A Lira; Nicholas W Lukacs
Journal:  Eur J Immunol       Date:  2010-04       Impact factor: 5.532

7.  Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine.

Authors:  Anja Krause; Yaqin Xu; Sara Ross; Wendy Wu; Ju Joh; Stefan Worgall
Journal:  Virol J       Date:  2011-07-29       Impact factor: 4.099

8.  Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells.

Authors:  Ki-Hye Kim; Young-Tae Lee; Hye Suk Hwang; Young-Man Kwon; Yu-Jin Jung; Youri Lee; Jong Seok Lee; Yu-Na Lee; Soojin Park; Sang-Moo Kang
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

9.  Human metapneumovirus M2-2 protein inhibits innate immune response in monocyte-derived dendritic cells.

Authors:  Junping Ren; Guangliang Liu; Jonathan Go; Deepthi Kolli; Guanping Zhang; Xiaoyong Bao
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

Review 10.  Differential roles of lung dendritic cell subsets against respiratory virus infection.

Authors:  Tae Hoon Kim; Heung Kyu Lee
Journal:  Immune Netw       Date:  2014-06-19       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.